| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| INS | SERPINC1 | ENSOGAP00000019490 | ENSOGAP00000004541 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Serpin family C member 1; Belongs to the serpin family. | 0.699 |
| INS | SERPINE1 | ENSOGAP00000019490 | ENSOGAP00000006875 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Serpin family E member 1; Belongs to the serpin family. | 0.642 |
| INS | SERPINE2 | ENSOGAP00000019490 | ENSOGAP00000013636 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Serpin family E member 2; Belongs to the serpin family. | 0.627 |
| INS | SLC2A1 | ENSOGAP00000019490 | ENSOGAP00000001862 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Solute carrier family 2 member 1; Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. | 0.495 |
| INS | SLC2A4 | ENSOGAP00000019490 | ENSOGAP00000003922 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Solute carrier family 2 member 4; Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. | 0.813 |
| INS | TP53 | ENSOGAP00000019490 | ENSOGAP00000015106 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Cellular tumor antigen p53; Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression; Belongs to the p53 family. | 0.461 |
| RAB10 | RAB14 | ENSOGAP00000009309 | ENSOGAP00000011624 | RAB10, member RAS oncogene family. | RAB14, member RAS oncogene family. | 0.871 |
| RAB10 | RAB2A | ENSOGAP00000009309 | ENSOGAP00000010030 | RAB10, member RAS oncogene family. | RAB2A, member RAS oncogene family. | 0.826 |
| RAB10 | RAB8A | ENSOGAP00000009309 | ENSOGAP00000012445 | RAB10, member RAS oncogene family. | RAB8A, member RAS oncogene family. | 0.883 |
| RAB10 | SLC2A1 | ENSOGAP00000009309 | ENSOGAP00000001862 | RAB10, member RAS oncogene family. | Solute carrier family 2 member 1; Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. | 0.605 |
| RAB10 | SLC2A4 | ENSOGAP00000009309 | ENSOGAP00000003922 | RAB10, member RAS oncogene family. | Solute carrier family 2 member 4; Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. | 0.910 |
| RAB14 | RAB10 | ENSOGAP00000011624 | ENSOGAP00000009309 | RAB14, member RAS oncogene family. | RAB10, member RAS oncogene family. | 0.871 |
| RAB14 | RAB2A | ENSOGAP00000011624 | ENSOGAP00000010030 | RAB14, member RAS oncogene family. | RAB2A, member RAS oncogene family. | 0.877 |
| RAB14 | RAB8A | ENSOGAP00000011624 | ENSOGAP00000012445 | RAB14, member RAS oncogene family. | RAB8A, member RAS oncogene family. | 0.837 |
| RAB14 | SLC2A1 | ENSOGAP00000011624 | ENSOGAP00000001862 | RAB14, member RAS oncogene family. | Solute carrier family 2 member 1; Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. | 0.796 |
| RAB14 | SLC2A4 | ENSOGAP00000011624 | ENSOGAP00000003922 | RAB14, member RAS oncogene family. | Solute carrier family 2 member 4; Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. | 0.884 |
| RAB2A | RAB10 | ENSOGAP00000010030 | ENSOGAP00000009309 | RAB2A, member RAS oncogene family. | RAB10, member RAS oncogene family. | 0.826 |
| RAB2A | RAB14 | ENSOGAP00000010030 | ENSOGAP00000011624 | RAB2A, member RAS oncogene family. | RAB14, member RAS oncogene family. | 0.877 |
| RAB2A | RAB8A | ENSOGAP00000010030 | ENSOGAP00000012445 | RAB2A, member RAS oncogene family. | RAB8A, member RAS oncogene family. | 0.786 |
| RAB2A | SLC2A1 | ENSOGAP00000010030 | ENSOGAP00000001862 | RAB2A, member RAS oncogene family. | Solute carrier family 2 member 1; Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. | 0.597 |